Clinical trial
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve…
NCT00401960 · Weill Medical College of Cornell University, Other · Terminated
Key facts
| NCT number | NCT00401960 |
|---|---|
| Title | Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis. |
| Official title | Open Label Study to Assess the Efficacy and Safety of Daptomycin in Combination With Anti-Cell Wall Active Therapy in the Treatment of Enterococcal Endocarditis |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Endocarditis, Bacterial |
| Intervention type | Drug |
| Interventions | Daptomycin |
| Enrollment | 6 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | May 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: